Options
探討洛神花萃取物及成分抑制血管病變之機制:對血管平滑肌增生以及移動能力之影響
Date Issued
2009
Author(s)
羅佳紋
Chia-Wen
Advisor
Abstract
動脈粥狀硬化是一種形成原因較為複雜的心血管疾病,也是冠狀動脈疾病及中風的重要致病機轉。在動脈粥狀硬化的形成過程中,平滑肌細胞在血管中層的增生以及往血管內皮下間隙的移動都是重要的致病步驟。洛神花,其名稱是由英名Roselle 音譯而來,學名為Hibiscus sabdariffa Linnaeus,分布在熱帶及亞熱帶地區,亦生長於台灣東部以及中南部。洛神花主要有效成分包含原兒茶酸(protocatechuic acid, PCA)、花青素 (anthocyanin)、類黃酮素 (flavonoid) 以及異黃酮 (isoflavonoid)。在之前的研究指出,洛神花水萃取物不但抑制低密度脂蛋白 (Low density lipoprotein,LDL)氧化,而且在動物實驗方面,將洛神花水萃取物餵食已先攝取高膽固醇之兔子及老鼠,其血管病變的指數都有顯著下降。另外,洛神花主要有效成分之一花青素 (anthocyanin),其廣泛存在於蔬菜、水果等植物中,許多報導均指出花青素具有抗氧化、降血脂以及預防癌症等作用。洛神花花青素也具有抑制低密度脂蛋白 (Low density lipoprotein, LDL)氧化,以達到預防動脈粥狀硬化的功效。最近也有報導指出,花青素經由人體吸收代謝後的主要的產物為原兒茶酸(protocatechuic acid,PCA),其不但為洛神花的活性成分之一,也是許多種藥材中的有效活性成分,具有抗氧化、抑制腫瘤細胞生長的作用。但洛神花水萃取物(Hibiscus sabdariffa extract,HSE)、洛神花之花青素(Hibiscus anthocyanin,HAs)及原兒茶酸(protocatechuic acid, PCA)對血管平滑肌的影響及作用機制目前則尚未清楚。本實驗擬探討洛神花水萃取物、洛神花之花青素 及原兒茶酸對血管平滑肌細胞增生與移動之影響及探討其作用機制。洛神花水萃物對平滑肌細胞(smooth muscle cell,SMC)之研究結果顯示,在洛神花水萃取物處理下,由血清刺激細胞增生現象可受到抑制。進一步以DNA斷裂以及流式細胞儀分析,洛神花水萃物藉由誘發細胞走向程序性凋亡(apoptosis),進而抑制增生。且透過活化細胞內 p-p38, c-jun, cytochrome c,及cleaved-caspase 3等apoptotic protein之表現,使平滑肌細胞透過此分子機制抑制血清刺激細胞增生現象。洛神花花青素對平滑肌細胞之研究結果顯示,在洛神花青素處理下,由血清刺激細胞增生現象可受到抑制。進一步以DNA斷裂以及流式細胞儀分析,洛神花花青素藉由誘發細胞走向程序性凋亡(apoptosis),進而抑制增生。且透過活化細胞內是透過p38/c-jun/FasL路徑。除此之外,在細胞處理洛神花花青素之後p53及Bax蛋白表現量均增加,且Bax與由caspase-8所活化的tBid的增加均造成粒腺體的cytochrome c釋出,接著活化caspase-3造成細胞凋亡。綜合這些實驗結果顯示,洛神花花青素所誘發細胞的凋亡路徑分別為p38/c-jun/FasL/及p53/Bax路徑,使平滑肌細胞細胞透過此分子機制抑制血清刺激細胞增生現象。在原兒茶酸對平滑肌細胞抑制其增生與移行能力及分子機轉探討。 結果顯示,在原兒茶酸處理下,由血清刺激所產生的細胞增生現象受到抑制。接著以流式細胞儀分析細胞的分裂週期,原兒茶酸抑制了細胞週期的進行,因此細胞分裂速度受到影響,進而抑制了細胞的增生。進一步探討原兒茶酸對細胞移行的影響,結果顯示,以0.25 至1 mM 原兒茶酸處理24小時後,由TNF-α引起的細胞移行皆被抑制,而傷口癒合試驗的結果也顯示相同的結果。最後針對原兒茶酸對基質金屬蛋白酵素(Matrix metalloproteinase,MMP)的影響,結果也顯示,由TNF-α刺激所產生的MMP-2及MMP-9活性的增加,皆受到原兒茶酸抑制。綜合實驗的結果顯示,原兒茶酸抑制血管平滑肌細胞的移行與增生。 此研究結果證實了,洛神花水萃物、洛神花花青素及原兒茶酸,抑制平滑肌細胞增生與移行的能力、以及其分子作用機轉,爲心血管疾病的預防與治療提供了一個新的選擇。
Hibiscus sabdariffa Linne (Malvaceae), an attractive plant believed to be native to Africa, is cultivated in Sudan as well as in eastern Taiwan. Our former study has shown Hibiscus sabdariffa extract (HSE) to be effective in combating atherosclerosis. In spite of the wide use of Hibiscus sabdariffa L. in folk medicine for treating various diseases, it has been reported to contain a number of protocatechuic acid and anthocyanins. In vitro experimental studies have shown that anthocyanins administration of the extract produces anti-inflammation and chemoprevention effects. Protocatechuic acid (PCA) is widely found in Chinese herbs. It has been reported that PCA represents antioxidative food components in a human diet rich in fruits and vegetables, and has been shown to prevent carcinogenesis or antitumor growth in vivo. At this time however, the mechanisms of HSE, Hibiscus anthocyanins (HAs) and PCA in attenuating atherosclerosis remain unclear. In HSE study, we found that HSE inhibited the serum-stimulated proliferation of smooth muscle cells (SMC) and triggered SMC to undergo apoptosis. The HSE-induced cell apoptosis was dose-dependent. We further used SB203580 (P38 inhibitor) to block cellular apoptosis. Our data showed possible potential in inhibiting SMC cell apoptosis via P38 MAPK pathway. HSE was found to induce P38 MAPK activation, thus stimulating the phosphorylation of c-jun. Therefore, HSE mediated cell death possibly via P38 MAPK signaling and then inhibited SMC proliferation. In HAs study, we found that Hibiscus anthocyanins (HAs) could inhibit the serum-stimulated proliferation of smooth muscle cell (SMC) and result in cell apoptosis. The HAs inducing cell apoptosis was dose dependent. We further used SB203580 (p38 inhibitor) to block cellular apoptosis and evaluate its effect on the HAs-inducing SMC death via some apoptosis criteria including DNA fragmentation and flow cytometry. We suggested that the mechanisms of the inhibitory effect of HAs on atherosclerosis could be via inhibiting the proliferation of SMC. HAs induces apoptosis via (i) activating p38 MAP kinase that subsequently phosphorylates target protein c-Jun and transduces the signal to further activate the apoptotic protein cascades that contain Fas-mediated signaling (Fas/caspase-8 signaling module) and (ii) activating p53 and inducing bax expression. As an outcome of the events, cytochrome c releases from the mitochondria, leading to cell apoptosis. In these experiments, HAs showed strong potential to induce SMC cell apoptosis via p38 and p53 pathway.In PCA study, this study examined the effects of PCA on migration and proliferation of cultured smooth muscle cells. First, the treatment of PCA 1-4 mM for 2-6 days exhibited serum-induced proliferation of smooth muscle cell was reduced. Next, flow cytometric assay showed that PCA could inhibit the cell cycle program of SMC. In addition, wounding assay showed that PCA could inhibit the TNF-α-stimulated MMP-2 and MMP-9 activity. These results demonstrated that PCA is effective in inhibiting both the proliferation and migration activity of SMC. These actions are likely to account for part of mechanisms underlying the therapeutic effects of HSE, HAs and PCA to treat atherosclerosis. Consequently, Hibiscus sabdariffa L. may be a useful natural component to prevent the pathological changes of atherosclerosis.
Type
thesis
File(s)
No Thumbnail Available
Name
097CSMU5107012-001.zip
Size
2.49 MB
Format
Unknown
Checksum
(MD5):6cb9a2404506716ee2faa509a92f5bdd